Zobrazit minimální záznam

Identifikace peptidického konjugátu s toxickým metabolitem paracetamolu N-acetyl-p-benzochinon iminem
dc.contributor.advisorMladěnka, Přemysl
dc.creatorLandíková, Kateřina
dc.date.accessioned2017-04-20T00:59:45Z
dc.date.available2017-04-20T00:59:45Z
dc.date.issued2010
dc.identifier.urihttp://hdl.handle.net/20.500.11956/24191
dc.description.abstractAcetaminophen (paracetamol) is one of the most used analgesic drug. It is considered as a safe drug, although its administration in large doses can lead to due to known metabolism to impairment of hepatocytes with subsequent necrosis. Acetaminophen is metabolized primarily in the liver where it is converted to inactive compound by conjugation with sulphate or glucoronide. However a small proportion is metabolized by hepatic cytochrome P450 enzymes to a minor but toxic intermediate metabolite N-acetyl-p- benzoquinone imine (NAPQI). This metabolite binds with the macromolecules of the hepatic cells causing dysfunction of the enzymatic systems, structural and metabolic disarray and eventually necrotic cell death. This thesis is a part of larger work intended for preparation polyclonal antibodies which can be used for further research in vivo / in vitro. The objectives of this study are a) the confirmation that NAPQI is the toxic intermediate that can react with free thiol groups and b) the in vitro production of the formed NAPQI-peptide conjugate. Using dexamethasone-induced rat liver microsomal fraction led to the expected production of NAPQI, that was linked on a synthetic peptide containing free thiol group. This adduct was collected and purified by HPLC with gradient elution. The outcome of this...en_US
dc.languageEnglishcs_CZ
dc.language.isoen_US
dc.publisherUniverzita Karlova, Farmaceutická fakulta v Hradci Královécs_CZ
dc.titleIdentifikace peptidického konjugátu s toxickým metabolitem paracetamolu N-acetyl-p-benzochinon iminemen_US
dc.typediplomová prácecs_CZ
dcterms.created2010
dcterms.dateAccepted2010-06-01
dc.description.departmentDepartment of Pharmacology and Toxicologyen_US
dc.description.departmentKatedra farmakologie a toxikologiecs_CZ
dc.description.facultyFaculty of Pharmacy in Hradec Královéen_US
dc.description.facultyFarmaceutická fakulta v Hradci Královécs_CZ
dc.identifier.repId67880
dc.title.translatedIdentifikace peptidického konjugátu s toxickým metabolitem paracetamolu N-acetyl-p-benzochinon iminemcs_CZ
dc.contributor.refereeVopršalová, Marie
dc.identifier.aleph001296982
thesis.degree.nameMgr.
thesis.degree.levelmagisterskécs_CZ
thesis.degree.disciplineFarmaciecs_CZ
thesis.degree.disciplinePharmacyen_US
thesis.degree.programFarmaciecs_CZ
thesis.degree.programPharmacyen_US
uk.thesis.typediplomová prácecs_CZ
uk.taxonomy.organization-csFarmaceutická fakulta v Hradci Králové::Katedra farmakologie a toxikologiecs_CZ
uk.taxonomy.organization-enFaculty of Pharmacy in Hradec Králové::Department of Pharmacology and Toxicologyen_US
uk.faculty-name.csFarmaceutická fakulta v Hradci Královécs_CZ
uk.faculty-name.enFaculty of Pharmacy in Hradec Královéen_US
uk.faculty-abbr.csFaFcs_CZ
uk.degree-discipline.csFarmaciecs_CZ
uk.degree-discipline.enPharmacyen_US
uk.degree-program.csFarmaciecs_CZ
uk.degree-program.enPharmacyen_US
thesis.grade.csVýborněcs_CZ
thesis.grade.enExcellenten_US
uk.abstract.enAcetaminophen (paracetamol) is one of the most used analgesic drug. It is considered as a safe drug, although its administration in large doses can lead to due to known metabolism to impairment of hepatocytes with subsequent necrosis. Acetaminophen is metabolized primarily in the liver where it is converted to inactive compound by conjugation with sulphate or glucoronide. However a small proportion is metabolized by hepatic cytochrome P450 enzymes to a minor but toxic intermediate metabolite N-acetyl-p- benzoquinone imine (NAPQI). This metabolite binds with the macromolecules of the hepatic cells causing dysfunction of the enzymatic systems, structural and metabolic disarray and eventually necrotic cell death. This thesis is a part of larger work intended for preparation polyclonal antibodies which can be used for further research in vivo / in vitro. The objectives of this study are a) the confirmation that NAPQI is the toxic intermediate that can react with free thiol groups and b) the in vitro production of the formed NAPQI-peptide conjugate. Using dexamethasone-induced rat liver microsomal fraction led to the expected production of NAPQI, that was linked on a synthetic peptide containing free thiol group. This adduct was collected and purified by HPLC with gradient elution. The outcome of this...en_US
uk.file-availabilityV
uk.publication.placeHradec Královécs_CZ
uk.grantorUniverzita Karlova, Farmaceutická fakulta v Hradci Králové, Katedra farmakologie a toxikologiecs_CZ
dc.identifier.lisID990012969820106986


Soubory tohoto záznamu

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

Tento záznam se objevuje v následujících sbírkách

Zobrazit minimální záznam


© 2017 Univerzita Karlova, Ústřední knihovna, Ovocný trh 560/5, 116 36 Praha 1; email: admin-repozitar [at] cuni.cz

Za dodržení všech ustanovení autorského zákona jsou zodpovědné jednotlivé složky Univerzity Karlovy. / Each constituent part of Charles University is responsible for adherence to all provisions of the copyright law.

Upozornění / Notice: Získané informace nemohou být použity k výdělečným účelům nebo vydávány za studijní, vědeckou nebo jinou tvůrčí činnost jiné osoby než autora. / Any retrieved information shall not be used for any commercial purposes or claimed as results of studying, scientific or any other creative activities of any person other than the author.

DSpace software copyright © 2002-2015  DuraSpace
Theme by 
@mire NV